{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T13:27:16Z","timestamp":1761744436121},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplant Immunology"],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1016\/j.trim.2017.01.001","type":"journal-article","created":{"date-parts":[[2017,1,12]],"date-time":"2017-01-12T11:00:43Z","timestamp":1484218843000},"page":"17-21","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Assignment of C1q-binding HLA antibodies as unacceptable HLA antigens avoids positive CDC-crossmatches prior to transplantation of deceased donor organs"],"prefix":"10.1016","volume":"41","author":[{"given":"David","family":"Juhl","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthias","family":"Marget","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Hallensleben","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Siegfried","family":"G\u00f6rg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Malte","family":"Ziemann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.trim.2017.01.001_bb0005","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1056\/NEJM196904032801401","article-title":"Significance of the positive crossmatch test in kidney transplantation","volume":"280","author":"Patel","year":"1969","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.trim.2017.01.001_bb0010","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1159\/000351459","article-title":"Luminex(\u00ae) and its applications for solid organ transplantation, hematopoietic stem cell transplantation, and transfusion","volume":"40","author":"Lachmann","year":"2013","journal-title":"Transfus. Med. Hemother."},{"key":"10.1016\/j.trim.2017.01.001_bb0015","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1097\/TP.0b013e31827a19cc","article-title":"Consensus guidelines on the testing and clinical management issues associated with HLA and non-HLA antibodies in transplantation","volume":"95","author":"Tait","year":"2013","journal-title":"Transplantation"},{"key":"10.1016\/j.trim.2017.01.001_bb0020","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1016\/j.transproceed.2014.07.053","article-title":"Virtual crossmatch in kidney transplantation","volume":"46","author":"Piazza","year":"2014","journal-title":"Transplant. Proc."},{"key":"10.1016\/j.trim.2017.01.001_bb0025","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1111\/j.1600-6143.2007.01667.x","article-title":"Pretransplant risk assessment in renal allograft recipients using virtual crossmatching","volume":"7","author":"Bielmann","year":"2007","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.trim.2017.01.001_bb0030","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1097\/TP.0b013e3182100f77","article-title":"No association of kidney graft loss with human leukocyte antigen antibodies detected exclusively by sensitive Luminex single-antigen testing: a collaborative transplant study report","volume":"91","author":"S\u00fcsal","year":"2011","journal-title":"Transplantation"},{"key":"10.1016\/j.trim.2017.01.001_bb0035","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1093\/ndt\/gfr429","article-title":"Clinical relevance of HLA donor-specific antibodies detected by single antigen assay in kidney transplantation","volume":"27","author":"Caro-Oleas","year":"2012","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.trim.2017.01.001_bb0040","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1097\/TP.0b013e31825ace2c","article-title":"Clinical relevance of anti-HLA donor-specific antibodies detected by Luminex assay in the development of rejection after renal transplantation","volume":"94","author":"Caro-Oleas","year":"2012","journal-title":"Transplantation"},{"key":"10.1016\/j.trim.2017.01.001_bb0045","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1111\/j.1432-2277.2012.01543.x","article-title":"Renal transplantation in sensitized recipients with positive luminex and negative CDC (complement-dependent cytotoxicity) crossmatches","volume":"25","author":"Huh","year":"2012","journal-title":"Transpl. Int."},{"key":"10.1016\/j.trim.2017.01.001_bb0050","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1016\/j.clinbiochem.2013.05.053","article-title":"Impact of alloantibody strength in crossmatch negative DSA positive kidney transplantation","volume":"46","author":"Wu","year":"2013","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.trim.2017.01.001_bb0055","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1681\/ASN.2009101065","article-title":"Preexisting donor-specific HLA antibodies predict outcome in kidney transplantation","volume":"21","author":"Lefaucheur","year":"2010","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.trim.2017.01.001_bb0060","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1111\/j.1600-6143.2011.03985.x","article-title":"Pretransplant donor-specific HLA class-I and -II antibodies are associated with an increased risk for kidney graft failure","volume":"12","author":"Otten","year":"2012","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.trim.2017.01.001_bb0065","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1097\/TP.0000000000000191","article-title":"Pretransplant immunologic risk assessment of kidney transplant recipients with donor-specific anti-human leukocyte antigen antibodies","volume":"98","author":"Marfo","year":"2014","journal-title":"Transplantation"},{"key":"10.1016\/j.trim.2017.01.001_bb0070","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1097\/TP.0b013e3181a5e034","article-title":"Clinical relevance of pretransplant donor-specific HLA antibodies detected by single-antigen flow-beads","volume":"87","author":"Amico","year":"2009","journal-title":"Transplantation"},{"key":"10.1016\/j.trim.2017.01.001_bb0075","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1111\/j.1399-0012.2012.01615.x","article-title":"Prognostic value and cost-effectiveness of different screening strategies for HLA antibodies prior to kidney transplantation","volume":"26","author":"Ziemann","year":"2012","journal-title":"Clin. Transpl."},{"key":"10.1016\/j.trim.2017.01.001_bb0080","doi-asserted-by":"crossref","first-page":"2809","DOI":"10.1111\/j.1600-6143.2007.01991.x","article-title":"C4d fixing, luminex binding antibodies - a new tool for prediction of graft failure after heart transplantation","volume":"7","author":"Smith","year":"2007","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.trim.2017.01.001_bb0085","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.healun.2010.08.020","article-title":"Clinical usefulness of a novel C1q assay to detect immunoglobulin G antibodies capable of fixing complement in sensitized pediatric heart transplant patients","volume":"30","author":"Chin","year":"2011","journal-title":"J. Heart Lung Transplant."},{"key":"10.1016\/j.trim.2017.01.001_bb0090","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1056\/NEJMoa1302506","article-title":"Complement-binding anti-HLA antibodies and kidney-allograft survival","volume":"369","author":"Loupy","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.trim.2017.01.001_bb0095","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1681\/ASN.2013101144","article-title":"Detection of C3d-binding donor-specific anti-HLA antibodies at diagnosis of humoral rejection predicts renal graft loss","volume":"26","author":"Sicard","year":"2015","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.trim.2017.01.001_bb0100","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1097\/TP.0b013e318203fd26","article-title":"C1q-fixing human leukocyte antigen antibodies are specific for predicting transplant glomerulopathy and late graft failure after kidney transplantation","volume":"15","author":"Yabu","year":"2011","journal-title":"Transplantation"},{"key":"10.1016\/j.trim.2017.01.001_bb0105","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/j.1399-3046.2011.01599.x","article-title":"Complement-fixing donor-specific antibodies identified by a novel C1q assay are associated with allograft loss","volume":"16","author":"Sutherland","year":"2012","journal-title":"Pediatr. Transplant."},{"key":"10.1016\/j.trim.2017.01.001_bb0115","series-title":"Technisches Handbuch Immungenetik","first-page":"58","article-title":"B-4 Antik\u00f6rper und Kreuzprobe","author":"Doxiadis","year":"1998"},{"key":"10.1016\/j.trim.2017.01.001_bb0120","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1097\/TP.0000000000000203","article-title":"Determinants of C1q binding in the single antigen bead assay","volume":"98","author":"Schaub","year":"2014","journal-title":"Transplantation"},{"key":"10.1016\/j.trim.2017.01.001_bb0125","doi-asserted-by":"crossref","first-page":"2421","DOI":"10.1111\/ajt.13295","article-title":"Assessing antibody strength: comparison of MFI, C1q, and titer information","volume":"15","author":"Tambur","year":"2015","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.trim.2017.01.001_bb0130","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/j.1600-6143.2007.02014.x","article-title":"Prospective age-matching in elderly kidney transplant recipients\u2014a 5-year analysis of the Eurotransplant senior program","volume":"8","author":"Frei","year":"2008","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.trim.2017.01.001_bb0135","doi-asserted-by":"crossref","first-page":"S14","DOI":"10.1016\/j.humimm.2011.07.022","article-title":"Luminex-C1q: a reliable virtual crossmatch (VXM) to predict final CDC crossmatch","volume":"72","author":"Chen","year":"2011","journal-title":"Hum. Immunol."},{"key":"10.1016\/j.trim.2017.01.001_bb0140","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1097\/MOT.0b013e328331c169","article-title":"Utility of the virtual crossmatch in solid organ transplantation","volume":"14","author":"Amico","year":"2009","journal-title":"Curr. Opin. Organ Transplant."},{"key":"10.1016\/j.trim.2017.01.001_bb0145","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1111\/j.1432-2277.2011.01235.x","article-title":"Risk stratification by the virtual crossmatch: a prospective study in 233 renal transplantations","volume":"24","author":"Amico","year":"2011","journal-title":"Transpl. Int."},{"key":"10.1016\/j.trim.2017.01.001_bb0150","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1111\/ajt.13606","article-title":"Renal transplantation with final allocation based on the virtual crossmatch","volume":"16","author":"Johnson","year":"2016","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.trim.2017.01.001_bb0155","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1097\/TP.0b013e31827b3dc3","article-title":"Systematic comparison of four cell- and Luminex-based methods for assessment of complement-activating HLA antibodies","volume":"95","author":"Lachmann","year":"2013","journal-title":"Transplantation"},{"key":"10.1016\/j.trim.2017.01.001_bb0160","first-page":"746395","article-title":"Artificially positive crossmatches not leading to the refusal of kidney donations due to the usage of adequate diagnostic tools","volume":"2013","author":"Schlaf","year":"2013","journal-title":"Case Rep. Transplant."},{"key":"10.1016\/j.trim.2017.01.001_bb0165","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1097\/TP.0b013e3181c926f2","article-title":"Ten-year experience of selective omission of the pretransplant crossmatch test in deceased donor kidney transplantation","volume":"89","author":"Taylor","year":"2010","journal-title":"Transplantation"},{"key":"10.1016\/j.trim.2017.01.001_bb0170","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.humimm.2012.10.012","article-title":"Modified solid-phase alloantibody detection for improved crossmatch prediction","volume":"74","author":"Wahrmann","year":"2013","journal-title":"Hum. Immunol."},{"key":"10.1016\/j.trim.2017.01.001_bb0175","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1681\/ASN.2016030368","article-title":"Value of donor-specific anti-HLA antibody monitoring and characterization for risk stratification of kidney allograft loss","volume":"28","author":"Viglietti","year":"2017","journal-title":"J. Am. Soc. Nephrol."}],"container-title":["Transplant Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0966327416300570?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0966327416300570?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,8,21]],"date-time":"2023-08-21T18:18:01Z","timestamp":1692641881000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0966327416300570"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3]]},"references-count":34,"alternative-id":["S0966327416300570"],"URL":"https:\/\/doi.org\/10.1016\/j.trim.2017.01.001","relation":{},"ISSN":["0966-3274"],"issn-type":[{"value":"0966-3274","type":"print"}],"subject":[],"published":{"date-parts":[[2017,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Assignment of C1q-binding HLA antibodies as unacceptable HLA antigens avoids positive CDC-crossmatches prior to transplantation of deceased donor organs","name":"articletitle","label":"Article Title"},{"value":"Transplant Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.trim.2017.01.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}